Advanced Enzyme Technologies Limited — Others, 10-02-2025: Copy of Newspaper Publication

Advanced Enzyme Technologies Limited has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The unaudited consolidated financial results will detail key performance metrics, influencing the company's operational strategies. This update may strengthen investor confidence, especially if it reflects solid revenue growth or effective cost management. Investors should consider potential volatility in the market response, depending on how these results align with expectations, reflecting either a positive outlook or areas of concern.